28/02/2007
In conformity with the Transparency Directive’s chapter 5 (DTR 5.6.1), the Board of ReGen Therapeutics PLC (the ‘Company’) announces the following:
As at the date of this announcement, the Company’s issued share capital consists of 846,146,110 Common Shares with a nominal value of 0.1 pence each, with voting
rights (‘Common Shares’).
The Company does not hold any Common Shares in Treasury.
Therefore the total number of Common Shares in the Company with voting rights is 846,146,110.
The above figure of 846,146,110 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.
For further information please contact:
Andrew Marshall
Greycoat Communications
Tel. 020 7960 6007
Rod Venables / Cecil Jordaan
HB Corporate
Tel. 020 7510 8561